Detalhe da pesquisa
1.
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.
Blood;
138(15): 1304-1316, 2021 10 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33974038
2.
Transfusion practices and complications in thalassemia.
Transfusion;
58(12): 2826-2835, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30260477
3.
The aggresome pathway as a target for therapy in hematologic malignancies.
Mol Genet Metab;
94(3): 283-6, 2008 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18472289
4.
High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA.
J Transplant;
2011: 740673, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21559259
5.
Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells.
Leuk Lymphoma;
52(8): 1544-55, 2011 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21699378
6.
ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.
Mol Cancer Ther;
9(3): 653-60, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20197394
7.
Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.
Cancer Res;
68(8): 2557-60, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18413721
8.
FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia.
Stem Cells;
24(5): 1174-84, 2006 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16410383